Outset Medical 9/6/22 DEADLINE: Lieff Cabraser Urges OM Investors to Contact Our Firm About Pending Securities Fraud Action

ACCESSWIRE
05 Aug 2022, 23:01 GMT+10

SAN FRANCISCO, CA / ACCESSWIRE / August 5, 2022 / National plaintiff's firm law firm of Lieff Cabraser Heimann & Bernstein, LLP stronglyrecommends thatOutset Medical (OM) investors who suffered losses between September 15, 2020 and June 13, 2022 contact our firmimmediately regarding pending securities fraud class action against Outset Medical. The deadline to apply to be a lead plaintiff is September 6, 2022.

Lieff Cabraser Heimann & Bernstein, Friday, August 5, 2022, Press release picture

Class Period: September 15, 2020 - June 13, 2022

Lead Plaintiff Motion Deadline: September 6, 2022

For more information: https://www.lieffcabraser.com/securities/outset-medical/

Contact Lieff Cabraser: investorinfo@lchb.com or 1-800-541-7358

The action alleges that Outset misled investors and/or failed to disclose material information about its chief product, the Tablo Hemodialysis System ('Tablo').

On May 4, 2022, after markets closed, Outset announced disappointing financial results for the first quarter of 2022, which analysts attributed in part to Tablo's untested performance in the home setting. On this news, the price of Outset common stock fell $16.88, or 2.26% over the next three trading days, from a closing price of $39.94 per share on Wednesday, May 4, 2022, to close at $23.06 per share on Monday, May 9, 2022, on elevated trading volume.

On June 13, 2022, after markets closed, Outset announced that the FDA required the Company to suspend all shipments of Tablo for home use until Outset obtained the requisite regulatory clearance. On this news, the price of Outset stock fell $6.95, or 34.05%, from a closing price of $20.41 per share on June 13, 2022, to close at $13.46 per share on June 14, 2022, on extremely heavy trading volume.

About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, with over 100 attorneys in offices in San Francisco, New York, Nashville, and Munich, Germany, is an internationally-recognized law firm committed to advancing the rights of investors and promoting corporate responsibility. Recognized as a 'Plaintiffs' Powerhouse' by Law360, Lieff Cabraser has litigated some of the most important civil cases in the United States, and has assisted clients in recovering over $124 billion in verdicts and settlements. Lieff Cabraser is committed to ensuring access to justice for all.

SOURCE: Lieff Cabraser Heimann & Bernstein

View source version on accesswire.com:
https://www.accesswire.com/710877/Outset-Medical-9622-DEADLINE-Lieff-Cabraser-Urges-OM-Investors-to-Contact-Our-Firm-About-Pending-Securities-Fraud-Action

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to California Telegraph.

More Information

95 ℉

Fair in Sacramento/Executive

International

Section

For second time, US to outlaw flavored e-cigarettes

WASHINGTON D.C.: Despite the U.S. Food and Drug Administration's 2016 crack downon fruity, sweet-flavored e-cigarettes that can cause teens to ...

UK reports highest number of foreign workers since COVID-19

LONDON, England: Official figures have been released indicating that in the year to June, the UK recorded its highest increase ...

US approves sale of hearing aids without medical prescriptions

WASHINGTON D.C.: The U.S. Food and Drug Administration has approved the sale of over-the-counter hearing aids for people with mild ...

Bachelet asks Bangladesh to probe enforced disappearance allegations

DHAKA, Bangladesh - Michelle Bachelet has urged the Bangladesh government to establish an independent investigation into allegations of enforced disappearances. ...